Literature DB >> 8968025

High fluoride intakes cause osteomalacia and diminished bone strength in rats with renal deficiency.

C H Turner1, I Owan, E J Brizendine, W Zhang, M E Wilson, A J Dunipace.   

Abstract

Renal insufficiency is known to increase plasma fluoride levels, which may increase the risk of fluorosis and osteomalacia. The purpose of this study was to determine the effects of fluoride on skeletal fragility and mineralization in renal-deficient animals. We evaluated the skeleton of rats with surgically induced renal deficiency (4/5 nephrectomy) that were chronically exposed to fluoridated water at concentrations of 0, 5, 15, and 50 ppm for a period of 6 months. The chosen fluoride doses caused plasma fluoride levels equivalent to those in humans consuming fluoridated water levels of 0, 1, 3, and 10 ppm, respectively. Animals with renal deficiency drank about 60% more water and excreted 85% more urine than control animals. Glomerular filtration rate (GFR) was decreased 68% and plasma BUN was increased fourfold in rats with renal deficiency. Plasma fluoride was strongly correlated with 1/GFR and was greatly increased by renal deficiency in all animals consuming fluoridated water. There was a strong positive, nonlinear relationship between plasma fluoride and bone fluoride levels, suggesting nonlinear binding characteristics of fluoride to bone. The amount of unmineralized osteoid in the vertebral bone was related to the plasma fluoride levels. Vertebral osteoid volume was increased over 20-fold in animals with renal deficiency that received 15 or 50 ppm fluoride, suggesting osteomalacia. Should osteomalacia be defined as a tenfold increase in osteoid volume, there appeared to be a threshold plasma fluoride level of about 20 micromol/L, above which osteomalacia was observed consistently. This plasma fluoride level was not achieved in control rats regardless of fluoride intake, nor was it achieved in renal-deficient rats receiving 0 or 5 ppm fluoride. A fluoride concentration of 50 ppm reduced femoral bone strength by 11% in control rats and by 31% in renal-deficient rats. Vertebral strength also was decreased significantly in renal-deficient rats given 50 ppm fluoride. In conclusion, fluoridated water in concentrations equivalent to 3 and 10 ppm in humans, caused osteomalacia and reduced bone strength in rats with surgically-induced renal deficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968025     DOI: 10.1016/s8756-3282(96)00278-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  14 in total

1.  Increasing fluoride content deteriorates rat bone mechanical properties.

Authors:  Taraneh Rezaee; Mary L Bouxsein; Lamya Karim
Journal:  Bone       Date:  2020-04-19       Impact factor: 4.398

2.  Determination of reference concentrations of strontium in urine by inductively coupled plasma atomic emission spectrometry.

Authors:  Kan Usuda; Koichi Kono; Satsuki Hayashi; Takashi Kawasaki; Go Mitsui; Takahiro Shibutani; Emi Dote; Kazuya Adachi; Michiko Fujihara; Yukari Shimbo; Wei Sun; Bo Lu; Kazuo Nakasuji
Journal:  Environ Health Prev Med       Date:  2006-01       Impact factor: 3.674

3.  Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men.

Authors:  Jean-Yves Reginster; Eric Abadie; Pierre Delmas; René Rizzoli; Willard Dere; Philippevan der Auwera; Bernard Avouac; Maria-Luisa Brandi; Anastasia Daifotis; Adolfo Diez-Perez; Gonzalo Calvo; Olof Johnell; Jean-Marc Kaufman; Gottfried Kreutz; Andrea Laslop; Fritz Lekkerkerker; Bruce Mitlak; Per Nilsson; John Orloff; Mary Smillie; Andrew Taylor; Yannis Tsouderos; Dominique Ethgen; Bruno Flamion
Journal:  Osteoporos Int       Date:  2005-08-10       Impact factor: 4.507

4.  Beneficial effects of vitamin E isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats.

Authors:  Muhammad Zulfadli Mehat; Ahmad Nazrun Shuid; Norazlina Mohamed; Norliza Muhammad; Ima Nirwana Soelaiman
Journal:  J Bone Miner Metab       Date:  2010-02-10       Impact factor: 2.626

5.  Fluoride exposure and kidney and liver function among adolescents in the United States: NHANES, 2013-2016.

Authors:  Ashley J Malin; Corina Lesseur; Stefanie A Busgang; Paul Curtin; Robert O Wright; Alison P Sanders
Journal:  Environ Int       Date:  2019-08-08       Impact factor: 9.621

6.  Quantitative (31)P NMR spectroscopy and (1)H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models.

Authors:  Haihui Cao; Ara Nazarian; Jerome L Ackerman; Brian D Snyder; Andrew E Rosenberg; Rosalynn M Nazarian; Mirko I Hrovat; Guangping Dai; Dionyssios Mintzopoulos; Yaotang Wu
Journal:  Bone       Date:  2010-02-24       Impact factor: 4.398

Review 7.  Strontium ranelate: a novel mode of action leading to renewed bone quality.

Authors:  Patrick Ammann
Journal:  Osteoporos Int       Date:  2005-01       Impact factor: 4.507

8.  Compressive axial mechanical properties of rat bone as functions of bone volume fraction, apparent density and micro-ct based mineral density.

Authors:  Esther Cory; Ara Nazarian; Vahid Entezari; Vartan Vartanians; Ralph Müller; Brian D Snyder
Journal:  J Biomech       Date:  2009-12-08       Impact factor: 2.712

9.  Comparison of failure mechanisms for cements used in skeletal luting applications.

Authors:  O Clarkin; D Boyd; M R Towler
Journal:  J Mater Sci Mater Med       Date:  2009-03-13       Impact factor: 3.896

10.  Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models.

Authors:  A Nazarian; E Cory; R Müller; B D Snyder
Journal:  Osteoporos Int       Date:  2008-05-31       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.